Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 30, 2017

View Archived Issues

Celgene agrees to acquire Delinia

Gene therapy GS-030 receives U.S. orphan status for retinitis pigmentosa

New trial will explore 5-ALA to prevent reduction in cardiac output after heart bypass surgery

Therapicon's melatonin formulation named U.S. orphan drug for necrotizing enterocolitis

Topline results from two pivotal phase III trials of SB-204 in patients with acne vulgaris

Ramot and Merck collaborate to develop antibody-drug conjugates for cancer

EMA's CHMP supports approval of Revlimid for post-ASCT maintenance therapy in MM

EMA committee gives positive opinion for Pfizer's Xeljanz

GreenPeptide initiates phase II trial of GRN-1201 for NSCLC in U.S.

Biogen presents promising data for the novel radiotracer MK-6240

Recordati's Cystadrops approved in E.U.

Scancell and Addario Lung Cancer Medical Institute collaborate on trials of SCIB-2

Phase Ib results for oral CC-122 in patients with advanced hepatocellular carcinoma

FDA approves Latuda to treat schizophrenia in adolescents

Amgen receives positive opinion for biosimilar adalimumab ABP-501

FDA maintains clinical hold on Regulus' RG-101 program

Topline results from phase III chronic constipation trial of linaclotide in Japan

GlaxoSmithKline discovers novel BMP-1 and TLL1/2 inhibitors

Sage Therapeutics presents new NMDA receptor ligands

Piramal Enterprises to acquire intrathecal spasticity and pain management drugs from Mallinckrodt

ViiV Healthcare UK identifies novel HIV integrase inhibitors

Research Council of Norway grant supports Bionor's development of Vacc-4x for HIV

Losartan given with FOLFIRINOX in phase II trial in locally advanced pancreatic cancer

Results from phase Ib trial of AM-0010 plus FOLFOX in metastatic pancreatic adenocarcinoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.